EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Apolipoprotein C3: form begets function

Karin E Bornfeldt

Journal of Lipid Research · 2024-01 · 65 (1) · 100475

DOI: 10.1016/j.jlr.2023.100475 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Lipid Research, 2024-01. Verfasst von Karin E Bornfeldt. Beteiligte Einrichtung: Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, UW Medicine Diabetes Institute and Department of Laboratory Medicine and…. Hauptthemen laut MEDLINE: Lipoproteins, Atherosclerosis. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased circulating levels of apolipoprotein C3 (APOC3) predict cardiovascular disease (CVD) risk in humans, and APOC3 promotes atherosclerosis in mouse models. APOC3's mechanism of action is due in large part to its ability to slow the clearance of triglyceride-rich lipoproteins (TRLs) and their remnants when APOC3 is carried by these lipoproteins. However, different pools and forms of APOC3 exert distinct biological effects or associations with atherogenic processes. Thus, lipid-free APOC3 induces inflammasome activation in monocytes whereas lipid particle-bound APOC3 does not. APOC3-enriched LDL binds better to the vascular glycosaminoglycan biglycan than does LDL depleted of APOC3. Patterns of APOC3 glycoforms predict CVD risk differently. The function of APOC3 bound to HDL is largely unknown. There is still much to learn about the mechanisms of action of different forms and pools of APOC3 in atherosclerosis and CVD, and whether APOC3 inhibition would prevent CVD risk in patients on LDL-cholesterol lowering medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipoproteinsAtherosclerosisMiceAnimalsHumansApolipoprotein C-IIITriglycerides

Stichwörter der Autor:innen

ApolipoproteinsAtherosclerosisInflammationLDLTriglyceridesVLDL

Substanzen

Apolipoprotein C-IIILipoproteinsTriglycerides

Autor:innen und Institutionen

  • Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, UW Medicine Diabetes Institute and Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. Electronic add…

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • National Heart Lung and Blood Institute
  • National Institutes of Health

Zitieren

APA

Bornfeldt, K. E. (2024). Apolipoprotein C3: form begets function. Journal of Lipid Research, 65(1), 100475. https://doi.org/10.1016/j.jlr.2023.100475

Vancouver

Bornfeldt KE. Apolipoprotein C3: form begets function. Journal of Lipid Research. 2024;65(1):100475. doi:10.1016/j.jlr.2023.100475

BibTeX
@article{Bornfeldt2024,
  author = {Bornfeldt, Karin E},
  title = {Apolipoprotein C3: form begets function},
  journal = {Journal of Lipid Research},
  year = {2024},
  volume = {65},
  number = {1},
  pages = {100475},
  doi = {10.1016/j.jlr.2023.100475}
}
Kostenlos starten →